Shanda Asset Management Holdings’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-10,000
| Closed | -$844K | – | 24 |
|
|
2019
Q2 | $844K | Hold |
10,000
| – | – | 0.16% | 17 |
|
|
2019
Q1 | $881K | Hold |
10,000
| – | – | 0.14% | 35 |
|
|
2018
Q4 | $714K | Hold |
10,000
| – | – | 0.13% | 37 |
|
|
2018
Q3 | $1.23M | Hold |
10,000
| – | – | 0.2% | 22 |
|
|
2018
Q2 | $982K | Hold |
10,000
| – | – | 0.15% | 32 |
|
|
2018
Q1 | $829K | Hold |
10,000
| – | – | 0.14% | 26 |
|
|
2017
Q4 | $776K | Hold |
10,000
| – | – | 0.12% | 33 |
|
|
2017
Q3 | $613K | Hold |
10,000
| – | – | 0.08% | 33 |
|
|
2017
Q2 | $460K | Hold |
10,000
| – | – | 0.07% | 28 |
|
|
2017
Q1 | $433K | Hold |
10,000
| – | – | 0.06% | 30 |
|
|
2016
Q4 | $387K | Hold |
10,000
| – | – | 0.07% | 24 |
|
|
2016
Q3 | $506K | Buy |
+10,000
| New | +$506K | 0.08% | 21 |
|